223 related articles for article (PubMed ID: 37410891)
1. Mechanisms of Nanoparticle Transport across Intestinal Tissue: An Oral Delivery Perspective.
Ejazi SA; Louisthelmy R; Maisel K
ACS Nano; 2023 Jul; 17(14):13044-13061. PubMed ID: 37410891
[TBL] [Abstract][Full Text] [Related]
2. The Influence of Nanoparticle Properties on Oral Bioavailability of Drugs.
Wang Y; Pi C; Feng X; Hou Y; Zhao L; Wei Y
Int J Nanomedicine; 2020; 15():6295-6310. PubMed ID: 32943863
[TBL] [Abstract][Full Text] [Related]
3. Oral drug delivery with polymeric nanoparticles: the gastrointestinal mucus barriers.
Ensign LM; Cone R; Hanes J
Adv Drug Deliv Rev; 2012 May; 64(6):557-70. PubMed ID: 22212900
[TBL] [Abstract][Full Text] [Related]
4. Enhanced oral absorption and anticancer efficacy of cabazitaxel by overcoming intestinal mucus and epithelium barriers using surface polyethylene oxide (PEO) decorated positively charged polymer-lipid hybrid nanoparticles.
Ren T; Wang Q; Xu Y; Cong L; Gou J; Tao X; Zhang Y; He H; Yin T; Zhang H; Zhang Y; Tang X
J Control Release; 2018 Jan; 269():423-438. PubMed ID: 29133120
[TBL] [Abstract][Full Text] [Related]
5. Nanoparticles for oral delivery: Design, evaluation and state-of-the-art.
Date AA; Hanes J; Ensign LM
J Control Release; 2016 Oct; 240():504-526. PubMed ID: 27292178
[TBL] [Abstract][Full Text] [Related]
6. Overcoming multiple gastrointestinal barriers by bilayer modified hollow mesoporous silica nanocarriers.
Wang Y; Zhao Y; Cui Y; Zhao Q; Zhang Q; Musetti S; Kinghorn KA; Wang S
Acta Biomater; 2018 Jan; 65():405-416. PubMed ID: 29037897
[TBL] [Abstract][Full Text] [Related]
7. Oral drug delivery with nanoparticles into the gastrointestinal mucosa.
Liu J; Leng P; Liu Y
Fundam Clin Pharmacol; 2021 Feb; 35(1):86-96. PubMed ID: 32749731
[TBL] [Abstract][Full Text] [Related]
8. Improved transport and absorption through gastrointestinal tract by PEGylated solid lipid nanoparticles.
Yuan H; Chen CY; Chai GH; Du YZ; Hu FQ
Mol Pharm; 2013 May; 10(5):1865-73. PubMed ID: 23495754
[TBL] [Abstract][Full Text] [Related]
9. Functional nanoparticles exploit the bile acid pathway to overcome multiple barriers of the intestinal epithelium for oral insulin delivery.
Fan W; Xia D; Zhu Q; Li X; He S; Zhu C; Guo S; Hovgaard L; Yang M; Gan Y
Biomaterials; 2018 Jan; 151():13-23. PubMed ID: 29055774
[TBL] [Abstract][Full Text] [Related]
10. Nanocarriers transport across the gastrointestinal barriers: The contribution to oral bioavailability via blood circulation and lymphatic pathway.
Wang D; Jiang Q; Dong Z; Meng T; Hu F; Wang J; Yuan H
Adv Drug Deliv Rev; 2023 Dec; 203():115130. PubMed ID: 37913890
[TBL] [Abstract][Full Text] [Related]
11. pH-sensitive dual drug loaded janus nanoparticles by oral delivery for multimodal analgesia.
Liu L; Yao W; Xie X; Gao J; Lu X
J Nanobiotechnology; 2021 Aug; 19(1):235. PubMed ID: 34362394
[TBL] [Abstract][Full Text] [Related]
12. Virus-Mimicking Mesoporous Silica Nanoparticles with an Electrically Neutral and Hydrophilic Surface to Improve the Oral Absorption of Insulin by Breaking Through Dual Barriers of the Mucus Layer and the Intestinal Epithelium.
Zhang Y; Xiong M; Ni X; Wang J; Rong H; Su Y; Yu S; Mohammad IS; Leung SSY; Hu H
ACS Appl Mater Interfaces; 2021 Apr; 13(15):18077-18088. PubMed ID: 33830730
[TBL] [Abstract][Full Text] [Related]
13. Engineering strategies to enhance nanoparticle-mediated oral delivery.
Yamanaka YJ; Leong KW
J Biomater Sci Polym Ed; 2008; 19(12):1549-70. PubMed ID: 19017470
[TBL] [Abstract][Full Text] [Related]
14. Role of nanoparticle size, shape and surface chemistry in oral drug delivery.
Banerjee A; Qi J; Gogoi R; Wong J; Mitragotri S
J Control Release; 2016 Sep; 238():176-185. PubMed ID: 27480450
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of mesoporous silica nanoparticles for oral drug delivery - current status and perspective of MSNs drug carriers.
Florek J; Caillard R; Kleitz F
Nanoscale; 2017 Oct; 9(40):15252-15277. PubMed ID: 28984885
[TBL] [Abstract][Full Text] [Related]
16. Comparative study of nanoparticle-mediated transfection in different GI epithelium co-culture models.
Loo Y; Grigsby CL; Yamanaka YJ; Chellappan MK; Jiang X; Mao HQ; Leong KW
J Control Release; 2012 May; 160(1):48-56. PubMed ID: 22326811
[TBL] [Abstract][Full Text] [Related]
17. Solid lipid matrix mediated nanoarchitectonics for improved oral bioavailability of drugs.
Banerjee S; Pillai J
Expert Opin Drug Metab Toxicol; 2019 Jun; 15(6):499-515. PubMed ID: 31104522
[No Abstract] [Full Text] [Related]
18. Uniform Core-Shell Nanoparticles with Thiolated Hyaluronic Acid Coating to Enhance Oral Delivery of Insulin.
Tian H; He Z; Sun C; Yang C; Zhao P; Liu L; Leong KW; Mao HQ; Liu Z; Chen Y
Adv Healthc Mater; 2018 Sep; 7(17):e1800285. PubMed ID: 29984479
[TBL] [Abstract][Full Text] [Related]
19. Oral Nanoparticles Exhibit Specific High-Efficiency Intestinal Uptake and Lymphatic Transport.
Kim KS; Suzuki K; Cho H; Youn YS; Bae YH
ACS Nano; 2018 Sep; 12(9):8893-8900. PubMed ID: 30088412
[TBL] [Abstract][Full Text] [Related]
20. Nanoparticles for oral delivery: targeted nanoparticles with peptidic ligands for oral protein delivery.
Yun Y; Cho YW; Park K
Adv Drug Deliv Rev; 2013 Jun; 65(6):822-32. PubMed ID: 23123292
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
